T1000	Speculation 171 178	whether
E1000	Speculation:T1000 Scope:T1001
T1001	Span 171 347	whether mutations in the glucocorticoid receptor could account for the increasing unresponsiveness of patients with chronic lymphatic leukemia (CLL) to combination chemotherapy
T1002	Negation 71 74	not
E1001	Negation:T1002 Scope:T1003
T1003	Span 71 127	not altered in mononuclear cells of treated CLL patients
T1004	Negation 623 625	no
E1002	Negation:T1004 Scope:T1005
T1005	Span 623 664	no clear correlation to clinical response
T1006	Speculation 220 225	could
E1003	Speculation:T1006 Scope:T1007
T1007	Span 220 347	could account for the increasing unresponsiveness of patients with chronic lymphatic leukemia (CLL) to combination chemotherapy
T1008	Speculation 812 822	suggesting
E1004	Speculation:T1008 Scope:T1009
T1009	Span 812 914	suggesting that the glucocorticoid receptor in the CLL patients tested is not altered in these domains
T1010	Negation 886 889	not
E1005	Negation:T1010 Scope:T1011
T1011	Span 886 914	not altered in these domains
T1012	Negation 1147 1151	lack
E1006	Negation:T1012 Scope:T1013
T1013	Span 1147 1179	lack of response to chemotherapy
T1014	Negation 942 945	not
E1007	Negation:T1014 Scope:T1015
T1015	Span 942 974	not been treated before analysis
T1016	Speculation 1120 1123	may
E1008	Speculation:T1016 Scope:T1017
T1017	Span 1120 1179	may be responsible for the lack of response to chemotherapy
T1018	Speculation 1039 1046	suggest
E1009	Speculation:T1018 Scope:T1019
T1019	Span 1039 1179	suggest that mechanisms other than altered ligand or DNA binding of the receptor may be responsible for the lack of response to chemotherapy
